Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Innovent Biologics
ISIN KYG4818G1010
|WKN A2N7N8
Market cap (in EUR)
15.797 m
Country
China
Sector
Salud
Dividend yield
0,00%
Overview
Quote
Description
Innovent Biologics, Inc. es una empresa biofarmacéutica que desarrolla, fabrica y comercializa medicamentos de alta calidad para el tratamiento del cáncer, enfermedades cardiovasculares y metabólicas, autoinmunes, oftalmológicas y otras enfermedades importantes. Opera a través de los siguientes segmentos geográficos: República Popular China (RPC), Estados Unidos de América (EE.UU.) e Indonesia. La empresa fue fundada por De Chao Yu, Kevin Chen y Scott M. Wheelwright el 28 de abril de 2011 y tiene su sede en Suzhou (China).
Salud Biofarmacéuticos Productos biofarmacéuticos no específicos del sistema China
Chart
Financials
Key metrics
| Market capitalisation, EUR | 15.797 m |
| EPS, EUR | - |
| P/B ratio | 6,6 |
| P/E ratio | 156,9 |
| Dividend yield | 0,00% |
Income statement (2025)
| Revenue, EUR | 1.608 m |
| Net income, EUR | 100 m |
| Profit margin | 6,24% |
What ETF is Innovent Biologics in?
There are 29 ETFs which contain Innovent Biologics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Innovent Biologics is the iShares BIC 50 UCITS ETF USD (Dist).
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
Detailed comparison of all offers
Source: justETF Research; as of 5/2026. The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
Performance
Returns overview
| YTD | +2.88% |
| 1 month | -7.46% |
| 3 months | -9.62% |
| 6 months | -8.41% |
| 1 year | +39.97% |
| 3 years | +98.44% |
| 5 years | -5.00% |
| Since inception (MAX) | +69.77% |
| 2025 | +95.94% |
| 2024 | -9.41% |
| 2023 | +21.04% |
| 2022 | -25.19% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 49.63% |
| Volatility 3 years | 54.71% |
| Volatility 5 years | 54.28% |
| Return per risk 1 year | 0.81 |
| Return per risk 3 years | 0.47 |
| Return per risk 5 years | -0.02 |
| Maximum drawdown 1 year | -27.40% |
| Maximum drawdown 3 years | -39.66% |
| Maximum drawdown 5 years | -76.41% |
| Maximum drawdown since inception | -79.28% |
Rolling 1 year volatility
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.